| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 可视化产品类(元) | 20,438,217.68 | 39,694,747.85 | 15,610,547.55 | 35,532,807.52 | 13,763,924.20 |
| 内镜耗材类(元) | 1,404,423,997.41 | 2,506,115,814.68 | 1,217,844,483.73 | 2,327,970,304.98 | 1,127,451,114.07 |
| 肿瘤介入类(元) | 84,304,659.88 | 192,732,129.00 | 114,029,645.56 | 218,243,092.93 | 111,217,088.89 |
| 其他(元) | 210,690,449.02 | 423,598,524.57 | 206,234,720.25 | 159,539,785.62 | 77,828,140.16 |
| 营业成本(元) | |||||
| 可视化产品类(元) | 19,624,973.90 | 34,106,725.84 | 13,219,659.54 | 17,557,442.79 | 6,752,040.30 |
| 内镜耗材类(元) | 424,908,635.41 | 802,366,670.23 | 388,355,669.09 | 725,062,672.56 | 346,957,227.26 |
| 肿瘤介入类(元) | 41,510,902.43 | 66,922,708.08 | 33,708,159.77 | 51,079,087.16 | 29,569,002.84 |
| 其他(元) | 113,644,476.60 | 224,795,318.85 | 107,441,556.63 | 90,152,110.85 | 41,553,648.68 |
| 毛利(元) | |||||
| 可视化产品类(元) | 813,243.78 | 5,588,022.01 | 2,390,888.01 | 17,975,364.73 | 7,011,883.90 |
| 内镜耗材类(元) | 979,515,362.00 | 1,703,749,144.45 | 829,488,814.64 | 1,602,907,632.42 | 780,493,886.81 |
| 肿瘤介入类(元) | 42,793,757.45 | 125,809,420.92 | 80,321,485.79 | 167,164,005.77 | 81,648,086.05 |
| 其他(元) | 97,045,972.42 | 198,803,205.72 | 98,793,163.62 | 69,387,674.77 | 36,274,491.48 |
| 毛利率(%) | |||||
| 可视化产品类(%) | 3.98 | 14.08 | 15.32 | 50.59 | 50.94 |
| 内镜耗材类(%) | 69.74 | 67.98 | 68.11 | 68.85 | 69.23 |
| 肿瘤介入类(%) | 50.76 | 65.28 | 70.44 | 76.60 | 73.41 |
| 其他(%) | 46.06 | 46.93 | 47.90 | 43.49 | 46.61 |
| 收入构成(%) | |||||
| 可视化产品类(%) | 1.19 | 1.26 | 1.00 | 1.30 | 1.03 |
| 内镜耗材类(%) | 81.66 | 79.25 | 78.38 | 84.92 | 84.75 |
| 肿瘤介入类(%) | 4.90 | 6.09 | 7.34 | 7.96 | 8.36 |
| 其他(%) | 12.25 | 13.40 | 13.27 | 5.82 | 5.85 |
| 毛利构成(%) | |||||
| 可视化产品类(%) | 0.07 | 0.27 | 0.24 | 0.97 | 0.77 |
| 内镜耗材类(%) | 87.44 | 83.77 | 82.05 | 86.30 | 86.20 |
| 肿瘤介入类(%) | 3.82 | 6.19 | 7.94 | 9.00 | 9.02 |
| 其他(%) | 8.66 | 9.77 | 9.77 | 3.74 | 4.01 |